DENIS CHEM LAB Financial Statement Analysis
|
||
The Revenues of DENIS CHEM LAB have increased by 4.34% YoY .
The Earnings Per Share (EPS) of DENIS CHEM LAB has increased by 42.05 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
DENIS CHEM LAB Last 5 Annual Financial Results
[BOM: 537536]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹168 Cr | ₹161 Cr | ₹137 Cr | ₹109 Cr | ₹136 Cr |
Expenses | ₹147 Cr | ₹142 Cr | ₹122 Cr | ₹99 Cr | ₹121 Cr |
Operating Profit (Excl OI) | ₹21 Cr | ₹19 Cr | ₹14 Cr | ₹10 Cr | ₹15 Cr |
Other Income | ₹1.39 Cr | ₹0.59 Cr | ₹1.05 Cr | ₹0.35 Cr | ₹0.28 Cr |
Interest | ₹0.54 Cr | ₹0.64 Cr | ₹0.76 Cr | ₹1.55 Cr | ₹2.89 Cr |
Depreciation | ₹6.95 Cr | ₹7.82 Cr | ₹5.76 Cr | ₹5.96 Cr | ₹6.66 Cr |
Profit Before Tax | ₹15 Cr | ₹11 Cr | ₹8.88 Cr | ₹3.09 Cr | ₹5.73 Cr |
Profit After Tax | ₹11 Cr | ₹7.86 Cr | ₹6.26 Cr | ₹2.26 Cr | ₹4.21 Cr |
Earnings Per Share (Rs) | ₹8.04 | ₹5.66 | ₹4.51 | ₹1.63 | ₹3.04 |
PAT Margin (%) | 6.65 | 4.89 | 4.59 | 2.07 | 3.10 |
ROE(%) | 14.62 | 11.33 | 9.79 | 3.76 | 7.29 |
ROCE(%) | 20.15 | 16.07 | 13.79 | 6.50 | 11.34 |
Total Debt/Equity(x) | 0.01 | 0.03 | 0.05 | 0.14 | 0.23 |
Key Financials |
||
Market Cap | : | ₹ 138.2 Cr |
Revenue (TTM) | : | ₹ 171.8 Cr |
Net Profit(TTM) | : | ₹ 10.1 Cr |
EPS (TTM) | : | ₹ 7.3 |
P/E (TTM) | : | 13.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
DENIS CHEM LAB | 5.4% | 9.3% | -32.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | 2.2% | 13.6% |
DIVIS LABORATORIES | 5.3% | 3.9% | 51.8% |
CIPLA | 3.3% | 1.2% | 9.7% |
TORRENT PHARMACEUTICALS | 4% | 6.3% | 29.2% |
DR REDDYS LABORATORIES | 6.1% | 2.3% | -3.2% |
MANKIND PHARMA | 9.9% | 18.9% | 14% |
ZYDUS LIFESCIENCES | -2.7% | -5.4% | -11.1% |
LUPIN | 2% | 0.9% | 20.4% |
DENIS CHEM LAB Revenues
[BOM: 537536]
Y-o-Y | 4.34 % |
5 Yr CAGR | 5.37 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹168 Cr | 4.34 | |
Mar2023 | ₹161 Cr | 17.79 | |
Mar2022 | ₹137 Cr | 24.92 | |
Mar2021 | ₹109 Cr | -19.71 | |
Mar2020 | ₹136 Cr | - |
DENIS CHEM LAB Operating Profit
[BOM: 537536]
Y-o-Y | 13.06 % |
5 Yr CAGR | 9.08 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹21 Cr | 13.06 | |
Mar2023 | ₹19 Cr | 30.86 | |
Mar2022 | ₹14 Cr | 39.97 | |
Mar2021 | ₹10 Cr | -31.65 | |
Mar2020 | ₹15 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 8.30 % |
5 Yr CAGR | 3.51 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 12.65% | 8.30 | |
Mar2023 | 11.68% | 11.13 | |
Mar2022 | 10.51% | 12.05 | |
Mar2021 | 9.38% | -14.88 | |
Mar2020 | 11.02% | - |
DENIS CHEM LAB Profit After Tax
[BOM: 537536]
Y-o-Y | 41.93 % |
5 Yr CAGR | 27.56 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 41.93 | |
Mar2023 | ₹7.86 Cr | 25.50 | |
Mar2022 | ₹6.26 Cr | 176.63 | |
Mar2021 | ₹2.26 Cr | -46.27 | |
Mar2020 | ₹4.21 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 35.99 % |
5 Yr CAGR | 21.02 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 6.65 % | 35.99 | |
Mar2023 | 4.89 % | 6.54 | |
Mar2022 | 4.59 % | 121.74 | |
Mar2021 | 2.07 % | -33.23 | |
Mar2020 | 3.1 % | - |
DENIS CHEM LAB Earnings Per Share (EPS)
[BOM: 537536]
Y-o-Y | 42.05 % |
5 Yr CAGR | 27.53 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹8.04 | 42.05 | |
Mar2023 | ₹5.66 | 25.50 | |
Mar2022 | ₹4.51 | 176.69 | |
Mar2021 | ₹1.63 | -46.38 | |
Mar2020 | ₹3.04 | - |
DENIS CHEM LAB Return on Capital Employed (ROCE)
[BOM: 537536]
Y-o-Y | 25.39 % |
5 Yr CAGR | 15.46 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 20.15% | 25.39 | |
Mar2023 | 16.07% | 16.53 | |
Mar2022 | 13.79% | 112.15 | |
Mar2021 | 6.5% | -42.68 | |
Mar2020 | 11.34% | - |
DENIS CHEM LAB Share Price vs Sensex
Current Share Price | : | ₹99.4 |
Current MarketCap | : | ₹ 138.2 Cr |
Updated EOD on | : | Apr 21,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DENIS CHEM LAB | 5.4% |
9.3% |
-32.1% |
SENSEX | 7.5% |
7.6% |
7% |
DENIS CHEM LAB related INDICES
You may also like the below Video Courses
FAQ about DENIS CHEM LAB Financials
How the annual revenues of DENIS CHEM LAB have changed ?
The Revenues of DENIS CHEM LAB have increased by 4.34% YoY .
How the Earnings per Share (EPS) of DENIS CHEM LAB have changed?
The Earnings Per Share (EPS) of DENIS CHEM LAB has increased by 42.05 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs